14-3-3theta Protects against Neurotoxicity in a Cellular Parkinson's Disease Model through Inhibition of the Apoptotic Factor Bax
2011

14-3-3theta Protects against Neurotoxicity in a Cellular Parkinson's Disease Model

publication Evidence: moderate

Author Information

Author(s): Slone Sunny R., Lesort Mathieu, Yacoubian Talene A.

Primary Institution: University of Alabama at Birmingham

Hypothesis

Disruption of 14-3-3 function by alpha-synuclein leads to the activation of pro-apoptotic pathways that are normally inhibited by 14-3-3s.

Conclusion

The study suggests that 14-3-3θ's neuroprotective effects against rotenone toxicity are mediated by the inhibition of the pro-apoptotic factor Bax.

Supporting Evidence

  • Overexpression of 14-3-3θ reduced cell death induced by the neurotoxin rotenone.
  • 14-3-3θ inhibited Bax activation and downstream signaling events, including cytochrome C release and caspase 3 activation.
  • Pharmacological inhibition or shRNA knockdown of Bax provided protection against rotenone toxicity.

Takeaway

This study shows that a protein called 14-3-3θ helps protect brain cells from damage in a model of Parkinson's disease by stopping another protein, Bax, from causing cell death.

Methodology

The study involved overexpressing 14-3-3θ in dopaminergic cell lines and assessing its effects on Bax activation and downstream apoptotic signaling in response to rotenone treatment.

Statistical Information

P-Value

p<0.01

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0021720

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication